8-aminoquinoline has been researched along with Malaria, Falciparum in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azhari, A; Blake, LD; Kemp, MT; Kyle, DE; Larsen, RW; Manetsch, R; McGaha, TW; McQueen, A; Namelikonda, N | 1 |
Alano, P; Baker, DA; Bhatia, SN; Biagini, GA; Camarda, G; Jirawatcharadech, P; Leung, S; March, S; Miller, AB; O'Neill, PM; Paine, MJI; Priestley, RS; Saif, A; Ward, SA; Wong, MHL | 1 |
Auburn, S; Baird, K; Bancone, G; Cheng, Q; Domingo, G; Espino, F; Green, J; Howes, R; McCarthy, J; Ménard, D; Moyes, C; Price, R; Shanks, D; Vestergaard, LS; von Seidlein, L; Winasti-Satyahraha, A; Yeung, S | 1 |
Abdul-Ghani, R; Beier, JC | 1 |
Iyer, PS; Kannan, M; Khan, FR; Raichurkar, AV | 1 |
Kaewpruk, N; Mungthin, M; Sitthichot, N; Suwandittakul, N; Tan-ariya, P; Ward, SA | 1 |
Chandra, S; Kumari, M; Subbarao, N; Tiwari, N | 1 |
Sullivan, DJ | 1 |
Brueckner, RP; Coster, T; Schuster, BG; Shmuklarsky, M; Wesche, DL | 1 |
3 review(s) available for 8-aminoquinoline and Malaria, Falciparum
Article | Year |
---|---|
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
Topics: Aminoquinolines; Clinical Laboratory Techniques; Drug-Related Side Effects and Adverse Reactions; Glucosephosphate Dehydrogenase Deficiency; Humans; Korea; Malaria, Falciparum; Malaria, Vivax | 2013 |
Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.
Topics: Aminoquinolines; Animals; Antimalarials; Artemisinins; Culicidae; Disease Eradication; Drug Resistance; Humans; Insect Vectors; Malaria, Falciparum; Plasmodium falciparum | 2014 |
Plasmodium drug targets outside the genetic control of the parasite.
Topics: Aminoquinolines; Animals; Antimalarials; Artemisinins; DNA, Protozoan; Drug Design; Drug Resistance; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
1 trial(s) available for 8-aminoquinoline and Malaria, Falciparum
Article | Year |
---|---|
Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.
Topics: Adult; Aminoquinolines; Animals; Antimalarials; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum | 1998 |
5 other study(ies) available for 8-aminoquinoline and Malaria, Falciparum
Article | Year |
---|---|
Synthesis, characterization, and cellular localization of a fluorescent probe of the antimalarial 8-aminoquinoline primaquine.
Topics: Aminoquinolines; Antimalarials; Erythrocytes; Fluorescent Dyes; Hep G2 Cells; Humans; Life Cycle Stages; Malaria, Falciparum; Microscopy, Fluorescence; Plasmodium falciparum; Primaquine | 2017 |
Antimalarial activity of primaquine operates via a two-step biochemical relay.
Topics: Aminoquinolines; Antimalarials; Bone Marrow; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Liver; Malaria, Falciparum; NADP; Pharmacokinetics; Plasmodium falciparum; Primaquine | 2019 |
Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.
Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Molecular Docking Simulation; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2015 |
PFMDR1 POLYMORPHISMS INFLUENCE ON IN VITRO SENSITIVITY OF THAI PLASMODIUM FALCIPARUM ISOLATES TO PRIMAQUINE, SITAMAQUINE AND TAFENOQUINE.
Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Primaquine; Thailand | 2016 |
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Topics: Aminoquinolines; Antimalarials; Chloroquine; Drug Design; Glutamyl Aminopeptidase; Humans; Malaria, Falciparum; Molecular Docking Simulation; Plasmodium falciparum; Quantitative Structure-Activity Relationship | 2016 |